Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NVAX compared with CYD: revenue, margins and what each company keeps, and the suppliers and customers both name
NVAX
Novavax Inc
Change
Mkt cap
Revenue
Revenue
CYD
China Yuchai International Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
NVAX
Novavax Inc
vs
CYD
China Yuchai International Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
NVAX
Novavax Inc
Change
9.51
· pre 9.53
· delayed
Mkt cap
$1.7B
Revenue
$57M
Q2 FY26
Revenue
$1.1B
FY25
CYD
China Yuchai International Ltd
Change
22.21
· pre 22.20
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$842.3M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 2 '26
delayed
NVAX
Novavax Inc
vs
CYD
China Yuchai International Ltd
9.51
pre 9.53
delayed
Price
22.21
pre 22.20
delayed
$1.7B
Mkt cap
$842.3M
Q2 FY26
$57M
Revenue
—
FY25
$1.1B
Revenue
—
Change
Change
NVAX
9.51
vs
CYD
22.21
Pre-market
Nov 2 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NVAX, solid
CYD, dashed
Supply-chain overlap
Revenue flow
NVAX: latest quarter is a loss; flow not drawable. CYD: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NVAX
13
PFE
Pfizer Inc. ("Pfizer")
customer
SNY
Sanofi
customer
TAK
Takeda
customer
—
AGC Biologics
unlisted
supplier
9 more · NVAX chain
›
Shared
0
No disclosed counterparties: CYD.
Only CYD
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR